[Lysophospholipid mediators]

Tanpakushitsu Kakusan Koso. 2009 Jan;54(1):29-39.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Physiological Phenomena
  • Drug Design
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents
  • Inflammation / etiology
  • Insulin / metabolism
  • Insulin Secretion
  • Lysophospholipids / metabolism
  • Lysophospholipids / physiology*
  • Neurotransmitter Agents / metabolism
  • Propylene Glycols / pharmacology
  • Receptors, G-Protein-Coupled / physiology
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Sphingosine / pharmacology
  • Sphingosine / physiology

Substances

  • Immunosuppressive Agents
  • Insulin
  • Lysophospholipids
  • Neurotransmitter Agents
  • Propylene Glycols
  • Receptors, G-Protein-Coupled
  • lysophosphatidylethanolamine
  • lysophosphatidylglycerol
  • lysophosphatidylinositol
  • lysophosphatidylserine
  • sphingosine 1-phosphate
  • Fingolimod Hydrochloride
  • Sphingosine
  • lysophosphatidic acid